"What can be more palpably absurd than the prospect held out of locomotives traveling twice as fast as stagecoaches?"
The Quarterly Review ; March edition, 1825
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8128964 | Transdermal pharmaceutical delivery composition A pharmaceutically delivery system is described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The dosage form may be in any pharmaceutically acceptable carrier means and ... | 03/06/2012 |
| 8114442 | Transdermal pharmaceutical delivery compositions A pharmaceutically delivery system and method of use therefor are described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The dosage form may be in any pharmaceutically a... | 02/14/2012 |
| 8110577 | Histone deacetylase inhibitors The present invention provides histone deacetylase inhibitors of general formula (I), a process for the preparation of such compounds and uses of the compounds in medicine, especially in the treatment of cancers and the inhibition of histone deacetylase activity. | 02/07/2012 |
| 7951904 | Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor The use of monoclonal antibodies to the angiotensin-II type-I receptor is provided for the treatment of cancer and vascular smooth muscle cell proliferation. Specifically, use is provided of a monoclonal antibody or a fragment thereof to a peptide comprising the N-t... | 05/31/2011 |
| 7683185 | Histone deacetylase inhibitors The present invention provides histone deacetylase inhibitors of general formula (I), process for the preparation of such compounds and uses of the compounds in medicine. ... | 03/23/2010 |
| 7629379 | Substituted phosphonate fluorescent sensors and use thereof The invention relates to new compounds of formula (1) wherein R is hydrogen or a linear or branched C1-40alkyl; where X is O, S, or NR1 where R1 is a hydrogen, a linear or branched C1-40 alkyl, C2-40 alkenyl or ... | 12/08/2009 |
| 7570956 | Intelligent control of radio resources in a wireless network A method of controlling radio resources in a cellular wireless network comprising a plurality of fixed antennas providing overlapping radio coverage, the method comprising dynamically adjusting the radiation patterns of the antennas using coordinated distributed con... | 08/04/2009 |
| 7498046 | Composition for inducing immune response comprising inverted microsomes A vaccine composition is provided which comprises inverted microsomes or fragments thereof from an animal cell in association with an externally disposed peptide antigen and a protein of the MHC. ... | 03/03/2009 |
| 7141392 | Latent fusion protein The present invention provides a method for providing latency to a pharmaceutically active agent. The method has application in overcoming the toxic effect of systemic administration of potent biological agents. The method comprises associating a fusion protein comp... | 11/28/2006 |
| 6942853 | Latent fusion protein This invention provides a nucleic acid construct comprising a first nucleic acid sequence encoding a pharmaceutically active agent and a second nucleotide sequence encoding a latency associated peptide, in which a nucleic acid sequence encoding a proteolytic cleavag... | 09/13/2005 |
| 6916653 | Ribozymal nucleic acid A vector system which can be incorporated in liposomes, comprising at least one DNA vector, the vector or vectors containing a target-cleaving hammerhead ribozymal DNA sequence under control of a promoter effective in human cells and which, upon transcription to RNA... | 07/12/2005 |
| 6852316 | Cancer treatment The present invention relates to the use of angiotensin in a method for the treatment or prevention of cancer. The method comprises administering to a patient in need of treatment an effective amount of an angiotensin. ... | 02/08/2005 |
| 6805864 | Type I angiotensin II receptor specific monoclonal antibodies and hybridomas The present invention relates to a novel hybridoma cell line which secretes monoclonal antibodies capable of binding to the AT1 subtype of the Angiotensin II receptor. It also relates to monoclonal antibodies secreted by the hybridoma, which antibodies ma... | 10/19/2004 |
| 6735529 | Predictive test for pre-eclampsia A method is provided which enables a prediction to be made about the risk of a pregnant woman developing pre-eclampsia which comprises an analysis of the serum levels of screening markers, Inhibin A and free β-hCG. Apparatus for carrying out the determination of th... | 05/11/2004 |
| 6689471 | Thermal management device and method of making such a device A thermal management device includes anisotropic carbon encapsulated in an encapsulating material that is applied directly to the anisotropic carbon, wherein the anisotropic carbon includes graphite. An electrical system includes the thermal management de... | 02/10/2004 |
| 6139860 | Method of stimulating cilia The present invention relates to the use of angiotensin II or an analogue thereof, for the manufacture of a medicament for stimulating cilia, such as fallopian tube cilia or bronchial epithelial cell cilia. Such a medicament may be used for promoting ovar... | 10/31/2000 |
| 6063620 | Type I angiotensin II receptor specific monoclonal antibodies and hybridomas The present invention relates to a novel hybridoma cell line which secretes monoclonal antibodies capable of binding to the AT1 subtype of the Angiotensin II receptor. It also relates to monoclonal antibodies secreted by the hybridoma, which an... | 05/16/2000 |
| 6011015 | Angiotensin II for improving fertilization Angiotensin II, or an analog thereof, can be used for promoting the fertilization of mammalian eggs. A method is disclosed for promoting in vitro fertilization of mammalian eggs using angiotensin II or a salt or an analogue thereof.... | 01/04/2000 |
| 5753615 | Neuropeptides and their use as insecticides This invention relates to novel neuropeptides isolated from Calliphora vomitoria, which are suitable for use in insecticidal formulations for controlling insects.... | 05/19/1998 |
| 5470803 | Method for the preparation of carbonated hydroxyapatite compositions A method for the preparation of a carbonated hydroxyapatite composition which has a density of at least 95% of the theoretical density, which method comprises sintering at substantially atmosphere pressure a green carbonated hydroxyapatite composition con... | 11/28/1995 |